Phase I study of WR-2721 and carboplatin
- 1 January 1993
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (8) , 1122-1127
- https://doi.org/10.1016/s0959-8049(05)80301-6
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Pharmacokinetics of WR-2721Pharmacology & Therapeutics, 1988
- Phase I/II trials of WR-2721 and cis-platinumInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Protection by WR-2721 of human bone marrow function following irradiationInternational Journal of Radiation Oncology*Biology*Physics, 1986
- PCNONLIN and NONLIN84: Software for the Statistical Analysis of Nonlinear ModelsThe American Statistician, 1986
- Results of NCI-sponsored phase I trials with carboplatinCancer Treatment Reviews, 1985
- A high-performance liquid chromatographic assay with improved selectivity for cisplatin and active platinum (II) complexes in plasma ultrafiltrateAnalytical Biochemistry, 1984
- A Liquid Chromatographic Electrochemical Assay for S-2-(3-Aminopropylamino) Ethylphosphorothioate (WR2721) in Human PlasmaJournal of Liquid Chromatography, 1984
- Pharmacokinetics of WR-1065 in mouse tissue following treatment with WR-2721International Journal of Radiation Oncology*Biology*Physics, 1984
- In vitro studies on the absorption of WR-2721 by tumors and normal tissuesInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976